The ultimate aim of the VI is to abolish high fragmentation in the PRD research landscape that largely stalls the progress towards new vaccines and drugs. This will improve the EU's competitiveness in poverty related diseases research field and will boost our fundamental knowledge to combat PRDs that alone account for more than six million deaths worldwide every year.